Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial

Annemieke Cats, Edwin P. M. Jansen, Nicole C.T. van Grieken, +92

The Lancet Oncology

Surgical OncologyChemotherapy Versus ChemoradiotherapyGastrointestinal OncologyResectable Gastric CancerMedicine +6

DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis

Linda M. Henricks, Carin A.T.C. Lunenburg, Femke M. de Man, +28

The Lancet Oncology

MedicineProspective Safety AnalysisCancer ManagementPharmacotherapyCancer Treatment +7

Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial

Stefanie de Groot, Rieneke T. Lugtenberg, Danielle Cohen, +33

Nature Communications

Melanoma-specific tumor-infiltrating lymphocytes but not circulating melanoma-specific T cells may predict survival in resected advanced-stage melanoma patients

John B.A.G. Haanen, Arnold Baars, Raquel Gomez, +9

Cancer Immunology Immunotherapy

Cancer ImmunosurveillanceMelanoma-specific T CellsMelanoma-specific Tumor-infiltrating LymphocytesMedicineMelanoma +7

Intradermal CpG-B Activates Both Plasmacytoid and Myeloid Dendritic Cells in the Sentinel Lymph Node of Melanoma Patients

Barbara G. Molenkamp, Paul A.M. van Leeuwen, Sybren Meijer, +6

Clinical Cancer Research

Expression of the Apoptosis Inhibitor Protease Inhibitor 9 Predicts Clinical Outcome in Vaccinated Patients with Stage III and IV Melanoma

Inge S. van Houdt, Joost J. Oudejans, Alfonsus Johannes Maria van den Eertwegh, +9

Clinical Cancer Research

A cost analysis of upfront DPYD genotype–guided dose individualisation in fluoropyrimidine-based anticancer therapy

Linda M. Henricks, Carin A.T.C. Lunenburg, Femke M. de Man, +28

European Journal of Cancer

Upfront DpydMedicineMetronomic TherapyPharmacologyPharmacotherapy +6

Late Release of Circulating Endothelial Cells and Endothelial Progenitor Cells after Chemotherapy Predicts Response and Survival in Cancer Patients

Jeanine M.L. Roodhart, Marlies H.G. Langenberg, Joost S.P. Vermaat, +5

Neoplasia

Skin tests predict survival after autologous tumor cell vaccination in metastatic melanoma: Experience in 81 patients

Arnold Baars, A.M.E. Claessen, A.J.M. van den Eertwegh, +9

Annals of Oncology

VaccinationTumor ImmunologyCancer ImmunosurveillanceMedicineSkin Tests +8

Local Adjuvant Treatment with Low-Dose CpG-B Offers Durable Protection against Disease Recurrence in Clinical Stage I–II Melanoma: Data from Two Randomized Phase II Trials

Bas D. Koster, Mari F.C.M. van den Hout, Berbel J.R. Sluijter, +8

Clinical Cancer Research